GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice.
<h4>Objective</h4>In addition to improve glucose intolerance, recent studies suggest that glucagon-like peptide-1 (GLP-1) receptor agonism also decreases triglyceride (TG) levels. The aim of this study was to evaluate the effect of GLP-1 receptor agonism on very-low-density lipoprotein (...
Guardado en:
Autores principales: | Edwin T Parlevliet, Yanan Wang, Janine J Geerling, Janny P Schröder-Van der Elst, Kristen Picha, Karyn O'Neil, Vedrana Stojanovic-Susulic, Tatiana Ort, Louis M Havekes, Johannes A Romijn, Hanno Pijl, Patrick C N Rensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22f65b1129434deb817148c89ddabf95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acute central neuropeptide Y administration increases food intake but does not affect hepatic very low-density lipoprotein (VLDL) production in mice.
por: Janine J Geerling, et al.
Publicado: (2013) -
Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Kay H. M. Roumans, et al.
Publicado: (2020) -
Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20
por: Gan Liu, et al.
Publicado: (2017) -
Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
por: Xu-Yun Zhao, et al.
Publicado: (2018) -
Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis
por: Liu B, et al.
Publicado: (2019)